5 Recruiting Studies Using Atra
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Atra
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Atrasentan in Patients With IgA Nephropathy
📍 University of Alabama at Birmingham — Birmingham, Alabama
IgA Nephropathy
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Atrasentan in Patients With Proteinuric Glomerular Diseases
📍 Kidney Disease Medical Group — Glendale, California
IgA Nephropathy
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
📍 Verspeeten Family Cancer Centre — London, Ontario
Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
📍 Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana
Relapsed Hodgkin Lymphoma
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
📍 Novartis Investigational site — Boston, Massachusetts
Immunoglobulin A Nephropathy
View Study & Checklist ➔